Virtual Library

Start Your Search

  • WCLC 2020

    2020 World Conference on Lung Cancer

    Conference Program for the 2020 World Conference on Lung Cancer

    Presentation Date(s):  
    • January 28 - 31, 2021
    • Total Presentations: 1597

    To review abstracts of the presentations below, narrow down your search by using the Filter options below, and then select the session listing of your choice. Click the "+" for a presentation to expand & view the corresponding Abstract details.

    Presentations will be available 24 hours after their live presentation time

Filter Results:

Show Only Available Presentations

  • +

    FP07 - Pathology

    • Type: Posters (Featured)
    • Track: Pathology, Molecular Pathology and Diagnostic Biomarkers
    • Presentations: 17
    • Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
    • +

      FP07.09 - Detection of Early Lung Cancer from Average-Risk Individuals and from Benign Nodule Carriers with a DNA Methylation Blood Test

      00:00 - 00:00  |  Presenter: Baohui Han

      • Abstract

      Loading...

  • +

    P14 - Immuno-biology and Novel Immunotherapeutics (Phase I and Translational) - Immuno-Biology

    • Type: Posters
    • Track: Immuno-biology and Novel Immunotherapeutics (Phase I and Translational)
    • Presentations: 30
    • Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
    • +

      P14.29 - Toripalimab in Combination with CIK Cells in Patients with Advanced NSCLC: An Exploratory Study

      00:00 - 00:00  |  Presenter: Baohui Han

      • Abstract

      Loading...

  • +

    P15 - Immuno-biology and Novel Immunotherapeutics (Phase I and Translational) - Novel Immunotherapeutics (Phase I)

    • Type: Posters
    • Track: Immuno-biology and Novel Immunotherapeutics (Phase I and Translational)
    • Presentations: 8
    • Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
    • +

      P15.07 - Safety and Efficacy Profile of TQB-2450 Alone/with Anlotinib in Previously-Treated Advanced NSCLC: A Phase IB Single-Arm Trial      

      00:00 - 00:00  |  Presenter: Baohui Han

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    P26 - Mesothelioma, Thymoma and Other Thoracic Malignancies - Thymic Malignancies

    • Type: Posters
    • Track: Mesothelioma, Thymoma and Other Thoracic Malignancies
    • Presentations: 10
    • Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
    • +

      P26.05 - Comprehensive Genomic Sequencing in Thymic Epithelial Tumors: Identification of Multiple Poor Prognosis Biomarkers in Chinese Patients

      00:00 - 00:00  |  Presenter: Baohui Han

      • Abstract

      Loading...

  • +

    P46 - Screening and Early Detection - Gene-Based Risk Stratification

    • Type: Posters
    • Track: Screening and Early Detection
    • Presentations: 7
    • Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
    • +

      P46.04 - Identify Lung Adenocarcinoma among Pulmonary Micro-nodules through Blood Gene Expression Profiles

      00:00 - 00:00  |  Presenter: Baohui Han

      • Abstract

      Loading...

    • +

      P46.05 - A Blood Six-Gene Test for Early-Stage Lung Adenocarcinoma Screening in Asympomatic Population

      00:00 - 00:00  |  Presenter: Baohui Han

      • Abstract

      Loading...

  • +

    P48 - Small Cell Lung Cancer/NET - Chemo - IO

    • Type: Posters
    • Track: Small Cell Lung Cancer/NET
    • Presentations: 23
    • Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
    • +

      P48.09 - Anlotinib Plus Etoposide and Carboplatin as First-Line Treatment for Extensive-Stage Small Cell Lung Cancer: A Single Arm Phase II Trial

      00:00 - 00:00  |  Presenter: Baohui Han

      • Abstract

      Loading...

  • +

    P62 - Tumor Biology and Systems Biology - Basic and Translational Science - Metabolomics

    • Type: Posters
    • Track: Tumor Biology and Systems Biology - Basic and Translational Science
    • Presentations: 10
    • Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
    • +

      P62.09 - PLGF Regulates Stimulation of Cell Proliferation and Glycolysis of Lung Adenocarcinoma Through Wnt/β-catenin Pathway

      00:00 - 00:00  |  Presenter: Baohui Han

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    P67 - Tumor Biology and Systems Biology - Basic and Translational Science - Proteomics

    • Type: Posters
    • Track: Tumor Biology and Systems Biology - Basic and Translational Science
    • Presentations: 1
    • Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
    • +

      P67.01 - Differential Proteomics Analysis on Plasma from Anlotinib-Treated Advanced Non-Small Cell Lung Cancer Patients

      00:00 - 00:00  |  Presenter: Baohui Han

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    P76 - Targeted Therapy - Clinically Focused - EGFR

    • Type: Posters
    • Track: Targeted Therapy - Clinically Focused
    • Presentations: 98
    • Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
    • +

      P76.10 - Erlotinib Plus Anlotinib as First-Line Therapy in Advanced Non-Small-Cell Lung Cancer Harboring EGFR Mutations: An Open-Label, Phase 2 Study

      00:00 - 00:00  |  Presenter: Tianqing Chu

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P76.59 - Rationale and Design of a Phase II Trial of Dacomitinib in Advanced NSCLC Patients with Uncommon EGFR Mutations

      00:00 - 00:00  |  Presenter: Baohui Han

      • Abstract

      Loading...

  • +

    P80 - Immunotherapy (Phase II/III Trials) - Immunotherapy Plus Chemotherapy/ Immunotherapy Plus Targeted Therapy

    • Type: Posters
    • Track: Immunotherapy (Phase II/III Trials)
    • Presentations: 1
    • Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
    • +

      P80.01 - A Multicenter, Randomized, Phase 3 Trial of Penpulimab in Combination With Anlotinib or Chemotherapy as First-Line Treatment in Advanced NSCLC

      00:00 - 00:00  |  Presenter: Baohui Han

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.